ClinicalTrials.Veeva

Menu

Benchmarking Integrated Care for People Living With Huntington's Disease in England (Integrate-HD)

U

University of Southampton

Status

Enrolling

Conditions

Huntington Disease

Treatments

Other: No intervention administered

Study type

Observational

Funder types

Other

Identifiers

NCT05828992
ERGO number: 77725

Details and patient eligibility

About

The survey and full study information can be accessed here: https://southampton.qualtrics.com/jfe/form/SV_8iEedDJZy4xaiI6

The goal of this anonymous survey is to benchmark integrated care from the perspective of service users in adults living with Huntington's Disease, including informal caregivers. The main question it aims to answer is: Is standard of care for people living with HD in England person-centred integrated care from the perspective of service users?

Participants will complete a one-time anonymous survey either online or on paper, according to their preference, that takes an average of 20-30 minutes. Participants can take breaks as needed, picking up the survey from where it was paused.

Full description

Huntington's disease (HD) is a rare brain disease that affects people's coordination, thinking and behaviour. It is a hereditary condition, affecting families across generations. Because its complex, it requires different sectors working together. Different surveys can be found in long term neurological conditions indicating care fragmentation and unmet severe needs, but evidence in HD is sparse.

Two surveys were identified covering people's needs in the UK, dated from 2006 and 2010. When looking for models or approaches tested to improve outcomes for people living with HD, no studies were found. This is an underserved population with complex needs and care gaps that remain unaddressed.

Little is known about to what extent people living with HD are experiencing care coordination between services and sectors in England. Integrate-HD aims to find out what good, joined-up care looks like. The study will explore the views and experiences of people living with HD, to identify the changes needed to improve people's care and quality of life.

Integrate-HD is a national survey to benchmark integrated care from the perspective of people living with HD, including informal caregivers.

The study objectives are to:

  1. Characterise and classify systems/organisations in England involved in HD care in relation to person-centred integrated care from the perspective of users.
  2. Identify areas considered integrated by service users.
  3. Identify areas considered fragmented by service users.
  4. Map care resources used by people living with HD in England.
  5. Identify unmet care needs that need improvement.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Adults with capacity living in England and fluent in English that are:

  • A person at risk of HD (where at least one parent is diagnosed with HD, therefore their offspring has 50% chance of developing the disease);
  • A person diagnosed with HD symptomatic or asymptomatic (after undergoing gene testing and having a positive result);
  • An informal caregiver supporting someone living with HD;
  • A former informal caregiver with experience of supporting someone living with HD in the last 3 years.

Exclusion criteria

  • Below 18 years old;
  • Not fluent in English;
  • A person without capacity.

Trial design

60 participants in 5 patient groups

Person at risk
Description:
Survey personalised for people living at risk of developing Huntington's Disease, meaning they have a parent diagnosed with HD but the person themselves have not undertaken a genetic test.
Treatment:
Other: No intervention administered
Person HD gene positive asymptomatic
Description:
Survey personalised for people that tested positive in their predictive genetic test but have not been yet diagnosed with clinical HD (manifest HD).
Treatment:
Other: No intervention administered
Person HD gene positive symptomatic
Description:
Survey personalised for people that tested positive in their predictive genetic test and have been diagnosed with clinical HD (manifest HD).
Treatment:
Other: No intervention administered
Informal caregiver
Description:
Survey personalised for people caring for another person diagnosed with HD.
Treatment:
Other: No intervention administered
Former informal caregiver
Description:
Survey personalised for people that have cared for another person diagnosed with HD in the last 3 years.
Treatment:
Other: No intervention administered

Trial contacts and locations

1

Loading...

Central trial contact

Sandra B Pires, MSc; Mari Carmen Portillo, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems